Proceedings of the National Academy of Sciences · 2012 · 206 citations · 27 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryMolecular PharmacologyBioactive Food ComponentsDiabetes ManagementDiabetes MellitusDiabetes PharmacotherapyInsulin ResistanceLipid MetabolismAntidiabetic ActivityAntidiabetic Drug TherapyDietary Management Of DiabetesMetabolic Disease PharmacotherapyNuclear Receptor TargetingPeroxisome Proliferator-activated Receptor Gamma RegulationPeroxisome Proliferator-activated Receptor SignalingPeroxisome Proliferator-activated Receptors
Given worldwide increases in the incidence of obesity and type 2 diabetes, new strategies for preventing and treating metabolic diseases are needed. The nuclear receptor PPARγ (peroxisome proliferator-activated receptor gamma) plays a central role in lipid and glucose metabolism; however, current PPARγ-targeting drugs are characterized by undesirable side effects. Natural products from edible biomaterial provide a structurally diverse resource to alleviate complex disorders via tailored nutritional intervention. We identified a family of natural products, the amorfrutins, from edible parts of two legumes, Glycyrrhiza foetida and Amorpha fruticosa, as structurally new and powerful antidiabetics with unprecedented effects for a dietary molecule. Amorfrutins bind to and activate PPARγ, which results in selective gene expression and physiological profiles markedly different from activation by current synthetic PPARγ drugs. In diet-induced obese and db/db mice, amorfrutin treatment strongly improves insulin resistance and other metabolic and inflammatory parameters without concomitant increase of fat storage or other unwanted side effects such as hepatoxicity. These results show that selective PPARγ-activation by diet-derived ligands may constitute a promising approach to combat metabolic disease.
27
Nonalcoholic Fatty Liver Disease
Giulio Marchesini, Mara Brizi, Giampaolo Bianchi et al. · Diabetes · 2001 · 2.6K citations · Full text
Medicine, Pathology, Hepatology +11
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
Robert T. Nolte, G. Bruce Wisely, Stefan Westin et al. · Nature · 1998 · 1.9K citations
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
Jang Hyun Choi, Alexander S. Banks, Jennifer L. Estall et al. · Nature · 2010 · 881 citations